Compounds > dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii
Page last updated: 2024-09-03

dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Adenocarcinoma

dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernhardt, G; Gust, R; Keller, C; Müller, R; Reile, H; Schönenberger, H; Spruss, T1

Other Studies

1 other study(ies) available for dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Adenocarcinoma

ArticleYear
Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3.
    Archiv der Pharmazie, 1992, Volume: 325, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured

1992